Lapatinib Completed Phase 2 Trials for Pediatric Cancers / Brain Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00883688Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma